Caricamento...
Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells
Gemcitabine, a novel pyrimidine nucleoside analog, has become the standard chemotherapeutic agent for pancreatic cancer patients. The clinical impact of gemcitabine remains modest owing to the high degree of inherent and acquired resistance. There are various lines of evidence that confirm the role...
Salvato in:
| Pubblicato in: | Cell Mol Biol Lett |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SP Versita
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276009/ https://ncbi.nlm.nih.gov/pubmed/21225469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/s11658-010-0043-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|